Although the introduction of serum PSA testing has greatly improved early detection rates and prediction of disease advancement, PSA between 4 and 10 ng/ml is still generally regarded as a “gray zone” because 60%-75% of men with PSA values in this range do not have PCa, which could cause this cohort to undergo unnecessary biopsies (17). Here, KLK3 is linked to posterior cortical atrophy.